389
Views
8
CrossRef citations to date
0
Altmetric
Clinical Study

Infectious Risk Factors for Atherosclerotic Vascular Disease in Hemodialysis Patients—Chlamydia pneumoniae but not Helicobacter pylori or Cytomegalovirus is Associated with Increased C‐Reactive Protein

, M.D., , M.D., , M.D., , M.D., , M.D. & , M.D.
Pages 279-287 | Published online: 07 Jul 2009

References

  • Cohen G., Haag‐Weber M., Horl W. H. Immune dysfunction in uremia. Kidney Int. 1997; 62(Suppl. 62)S79–S82, [CSA]
  • Schollmeyer P., Bozkurt F. The immune status of the uremic patient: hemodialysis vs. CAPD. Clin. Nephrol. 1988; 30(Suppl. 1)S37–S40, [PUBMED], [INFOTRIEVE]
  • Murray L. J., Bamford K. B., O'Reilly D. P., McCrum E. E., Evans A. E. Helicobacter pylori infection: relation with cardiovascular risk factors, ischemic heart disease, and social class. Br. J. Heart 1995; 74: 497–501
  • Kuo C. C., Grayston J. T., Campbell L. A., Goo Y. A., Wissler R. W., Benditt E. P. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15–34 years old). Proc. Natl. Acad. Sci., U. S. A. 1995; 92: 6911–6914, [PUBMED], [INFOTRIEVE]
  • Muhlestein J. B., Hammond E. H., Carlquist J. F., Radicke E., Thomson M. J., Karagounis L. A., Woods M. L., Anderson J. L. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J. Am. Coll. Cardiol. 1996; 27: 1555–1561, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Nieto F. J., Adam E., Sorlie P., Farzadegan H., Melnick J. L., Comstock G. W., Szklo M. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal‐medial thickening, a measure of subclinical atherosclerosis. Circulation 1996; 94: 922–927, [PUBMED], [INFOTRIEVE], [CSA]
  • Hoen B., Paul‐Dauphin A., Hestin D., Kessler M. EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J. Am. Soc. Nephrol. 1998; 9: 869–876, [PUBMED], [INFOTRIEVE], [CSA]
  • Sander D., Winbeck K., Klingelhofer J., Etgen T., Conrad B. Reduced progression of early carotid atherosclerosis after antibiotic treatment and Chlamydia pneumoniae seropositivity. Circulation 2002; 106: 2428–2433, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Wilson R. F., Marcus M. L., Christensen B. V., Talman C., White C. W. Accuracy of exercise electrocardiography in detecting physiologically significant coronary arterial lesions. Circulation 1991; 83: 412–421, [PUBMED], [INFOTRIEVE]
  • Detrano R., Gianrossi R., Mulvihill D., Lehmann K., Dubach P., Colombo A., Froelicher V. Exercise‐induced ST segment depression in the diagnosis of multivessel coronary disease: a meta analysis. J. Am. Coll. Cardiol. 1989; 14: 1501–1508, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Suurkula M., Agewall S., Fagerberg B., Wendelhag I., Widgren B., Wikstrand J. Ultrasound evaluation of atherosclerotic manifestations in the carotid artery in high‐risk hypertensive patients. Risk Intervention Study (RIS) Group. Arterioscler. Thromb. 1994; 14: 1297–1304, [PUBMED], [INFOTRIEVE]
  • Groh A., Prankratova V., Lipson M., Ben‐Michael M., Horovitz O., Mosckovitz R. SeroCP—a serological assay for the detection of Chlamydia pneumoniae IgG, IgA and IgM antibodies. Infect. Dis. Obstet. Gynecol. 1996; 4: 196–197
  • Peeling R. W., Wang S. P., Grayston J. T., Blasi F., Boman J., Clad A., Freidank H., Gaydos C. A., Gnarpe J., Hagiwara T., Jones R. B., Orfila J., Persson K., Puolakkainen M., Saikku P., Schachter J. Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results. J. Infect. Dis. 2000; 181(Suppl. 3)S426–S429, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Persson K., Boman J. Comparison of five serologic tests for diagnosis of acute infections by Chlamydia pneumoniae. Clin. Diagn. Lab. Immunol. 2000; 7: 739–744, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Verkooyen R. P., Willemse D., Hiep‐van Casteren S. C., Joulandan S. A., Snijder R. J., van den Bosch J. M., van Helden H. P., Peeters M. F., Verbrugh H. A. Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections. J. Clin. Microbiol. 1998; 36: 2301–2307, [PUBMED], [INFOTRIEVE], [CSA]
  • Hermann C., Graf K., Groh A., Straube E., Hartung T. Comparison of eleven commercial tests for Chlamydia pneumoniae‐specific G. immunoglobulin, in asymptomatic healthy individuals. J. Clin. Microbiol. 2002; 40: 1603–1609, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Halvorsen D. S., Borvik T., Njolstad I., Gutteberg T. J., Vorland L. H., Hansen J. B. Chlamydia pneumoniae IgA‐ and IgG antibodies in young survivors of myocardial infarction. A comparison of antibody detection by a microimmunofluorescence test and an enzyme immunoassay. J. Intern. Med. 2002; 251: 142–147, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Ma K. W., Greene E. L., Raij L. Cardiovascular risk factors in chronic renal failure and hemodialysis populations. J. Am. Kidney Dis. 1992; 19: 505–513
  • Descamps‐Latscha B., Chatenoud L. T cells B. and, cells in chronic renal failure. Semin. Nephrol. 1996; 16: 183–191, [CSA]
  • Haag‐Weber M., Horl W. H. The immune system in uremia and during its treatment. New Horiz. 1995; 3: 669–679, [CSA]
  • Stenvinkel P., Heimburger O., Jogestrand T. Elevated interleukin‐6 predicts progressive carotid artery atherosclerosis in dialysis patients: association with Chlamydia pneumoniae seropositivity. J. Am. Kidney Dis. 2002; 39: 274–282, [CSA]
  • Haubitz M., Brunkhorst R. C‐reactive protein and chronic Chlamydia pneumoniae infection‐long‐term predictors for cardiovascular disease and survival in patients on peritoneal dialysis. Nephrol. Dial. Transplant. 2001; 16: 809–815, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Zimmermann J., Herrlinger S., Pruy A., Metzger T., Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999; 55: 648–658, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Zoccali C., Benedetto F. A., Mallamaci F., Tripepi G., Fermo I., Foca A., Paroni R., Malatino L. S. Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular risk extended evaluation in dialysis patients. J. Hypertens. 2000; 18: 1207–1213, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Zhang L., Ishikawa Y., Akasaka Y., Ito K., Gregory S., Ishii T. Limited association of Chlamydia pneumoniae detection with coronary atherosclerosis. Atherosclerosis 2003; 167: 81–88, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Zahn R., Schneider S., Frilling B., Seidl K., Tebbe U., Weber M., Gottwik M., Altmann E., Seidel F., Rox J., Hoffler U., Neuhaus K. L., Senges J. Antibiotic therapy after acute myocardial infarction: a prospective randomized study. Circulation 2003; 107: 1253–1259, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Xu Q., Kiechl S., Mayr M., Metzler B., Egger G., Oberhollenzer F., Willeit J., Wick G. Association of serum antibodies to heat‐shock protein 65 with carotid atherosclerosis: clinical significance determined in a follow‐up study. Circulation 1999; 100: 1169–1174, [PUBMED], [INFOTRIEVE]
  • Xu Q. Role of heat shock proteins in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2002; 22: 1547–1559, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Mayr M., Kiechl S., Mendall M. A., Willeit J., Wick G., Xu Q. Increased risk of atherosclerosis is confined to CagA‐positive Helicobacter pylori strains: prospective results from the Bruneck study. Stroke 2003; 34: 610–615, [PUBMED], [INFOTRIEVE], [CROSSREF]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.